Yang, Lin
Alyasova, Anna
Ye, Dingwei
Ridolfi, Antonia
Dezzani, Luca
Motzer, Robert J.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
MSK Cancer Center Support Grant/Core Grant (P30 CA008748)
Article History
Received: 20 June 2017
Accepted: 5 February 2018
First Online: 17 February 2018
Authors’ information
: not applicable.
: The study was conducted in accordance with the International Conference on Harmonisation Good Clinical Practice guidelines, and approved by institutional review boards or independent ethics committees at each center. All patients provided written informed consent.
: not applicable.
: AA received compensation from Novartis for research. AR and LD are employees of Novartis Pharmaceuticals Corp. RJM received compensation from Novartis, BMS, Pfizer, Genentech/Roche and Eisai for research and from Novartis, Pfizer, and Eisai for consulting. LY and DY have declared no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.